Faced with an aging population, ophthalmologists must diagnose a growing number of patients suffering from diseases, such as diabetic retinopathy, AMD, glaucoma – and so they are under increasing pressure to improve practice efficiency. Optos’ Monaco is the world’s first ultra-widefield (UWF) retinal imaging device with integrated spectral domain Optical Coherence Tomography (OCT). This unique device – and its associated software – enables greater analysis of retinal health and increased diagnostic capability, all while improving clinic flow.
Speed is intrinsic to the Monaco – it takes less than half a second to produce a 200° single-capture optomap® image and provide cross-sectional 40° OCT views of retinal structures. Rapid multi-modality capture is also available, featuring color, autofluorescence and OCT scans for both eyes in just 90 seconds.
Imaging speed isn’t the only benefit of Monaco. The innovative instrument provides eyecare professionals with another route to improved practice efficiency. By combining two devices, space is saved and patient flow through the clinic can be hastened. There is also no need for dilation prior to imaging, offering patients a more convenient and comfortable exam.
Beyond speed and efficiency-boosting benefits, the system has an even more profound benefit for patients: it helps practitioners diagnose conditions that would otherwise be missed. The images produced by the Monaco can be correlated to enable a more in-depth pathology exam, enabling potentially sight-threatening conditions to be discovered and treated at an earlier stage – giving peace of mind to ophthalmologists and patients alike.
“Monaco has the potential to set practices apart in an increasingly competitive marketplace, not only improving the consultation experience, but improving outcomes for patients. Put simply, it is protecting – and, in some cases, saving – the sight of patients,” says Gareth Steer, Vice President of Sales, Europe, Optos.
The Monaco joins many other innovative retinal imaging devices in Optos’ repertoire, which together enable the company to lead the market in eyecare imaging solutions. “We employ engineers and scientists from across a range of disciplines who are involved in research, hardware development and software development for our world-leading technology. It is their work that allows our cutting-edge devices to help save patients’ sight and lives,” adds Steer. “Our goal is to provide outstanding technology and customer service to the practices that we work with, to help them provide the best possible care for their patients.”
For more information, visit optos.com.
